Rocket Pharmaceuticals (RCKT) shares were up almost 2% in Wednesday trading after Needham upgraded the stock to buy from hold, with a price target of $9.
Trading volume stood at more than 1.7 million shares, compared with a daily average of about 2 million.
Price: $3.48, Change: $+0.07, Percent Change: +1.91%